A retrospective comparison of clinical outcomes and quality of life measures between definitive chemoradiation alone and radical surgery for clinical stage II-III esophageal carcinoma

Journal of Surgical Oncology

Volumn 100, Issue 6, 2009, Pages 435-441

  Yamashita, Hideomi ^a   Okuma, Kae ^a   Seto, Yasuyuki ^a   Mori, Kazuhiko ^a   Kobayashi, Shino ^a   Wakui, Reiko ^a   Ohtomo, Kuni ^a   Nakagawa, Keiichi ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Chemoradiation; Esophageal cancer; Esophagectomy; Quality of life

Indexed keywords

CISPLATIN; FLUOROURACIL; NEDAPLATIN;

ADJUVANT THERAPY; ADULT; AGED; ANASTOMOSIS LEAKAGE; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; DISEASE FREE INTERVAL; ESOPHAGUS CARCINOMA; ESOPHAGUS HEMORRHAGE; ESOPHAGUS RECONSTRUCTION; ESOPHAGUS RESECTION; ESOPHAGUS SURGERY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; LEUKOPENIA; LUNG DISEASE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION INJURY; RECURRENT LARYNGEAL NERVE PALSY; SURVIVAL; THORACOTOMY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL RATE;

EID: 70350324958     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21361     Document Type: Article

References (34)

1. Ando N, Ozawa S, Kitagawa Y, et al.: Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 2000;232:225-232. (Pubitemid 30616724)
2. Rice TW, Adelstein DJ, Chidel MA, et al.: Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg 2003;126:1590-1596.
3. Malthaner RA, Wong RK, Rumble RB, et al.: Members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: A systematic review and meta-analysis. BMC Med 2004;2:35.
4. Akiyama H, Tsurumaru M, Udagawa H, et al.: Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994;220:372-373.
5. Herskovic A, Martz K, al-Sarraf M, et al.: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-1598.
6. Cooper JS, Guo MD, Herskovic A, et al.: Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623-1627. (Pubitemid 29211772)
7. Araújo CM, Souhami L, Gil RA, et al.: A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 1991;67:2258-2261.
8. Wilson KS, Lim JT: Primary chemo-radiotherapy and selective oesophagectomy for oesophageal cancer: Goal of cure with organ preservation. Radiother Oncol 2000;54:129-134.
9. Muller JM, Erasmi H, Stelzner M, et al.: Surgical therapy of oesophageal carcinoma. Br J Surg 1990;77:845-857. [Review].
10. Wobst A, Audisio RA, Colleoni M, et al.: Oesophageal cancer treatment: Studies, strategies and facts. Ann Oncol 1998;9:951-962. [Review]. (Pubitemid 28496702)
11. Chiu PW, Chan AC, Leung SF, et al.: Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: Early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 2005;9:794-802.
12. Bonnetain F, Bouché O, Michel P, et al.: A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): Chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol 2006;17:827-834.
13. Blazeby JM, Williams MH, Brookes ST, et al.: Quality of life measurement in patients with oesophageal cancer. Gut 1995;37:505-508.
14. Homs MY, Essink-Bot ML, Borsboom GJ, et al.: Quality of life after palliative treatment for oesophageal carcinoma - A prospective comparison between stent placement and single dose brachytherapy. Eur J Cancer 2004;40:1862-1871.
15. de Boer AG, van Lanschot JJ, van Sandick JW, et al.: Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol 2004;22:4202-4208.
16. Brooks JA, Kesler KA, Johnson CS, et al.: Prospective analysis of quality of life after surgical resection for esophageal cancer: Preliminary results. J Surg Oncol 2002;81:185-194.
17. National Comprehensive Cancer Network Panel Members. Esophageal cancer - Clinical practice guidelines in oncology. J Natl Comp Cancer Network 2003;1:14-27.
18. Enzinger PC, Mayer R: Esophageal cancer. N Engl J Med 2003;349:2241-2252.
19. Bosset JF, Gignoux M, Triboulet JP, et al.: Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337:161-167. (Pubitemid 27306287)
20. Burmeister BH, Smithers BM, Gebski V, et al.: Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase III trial. Lancet Oncol 2005;6:659-668. (Pubitemid 41222756)
21. Kelsen DP: Multimodality therapy of local regional esophageal cancer. Semin Oncol 2005;32:S6-S10. (Pubitemid 43084696)
22. Urba SG, Orringer MB, Turrisi A, et al.: Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:305-313. (Pubitemid 32112841)
23. Tepper J, Krasna MJ, Niedzwiecki D, et al.: Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008;26:1086-1092.
24. Gebski V, Burmeister B, Smithers BM, et al.: Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis. Lancet Oncol 2007;8:226-234. (Pubitemid 46291702)
25. Ishikura S, Nihei K, Ohtsu A, et al.: Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003;21:2697-2702. (Pubitemid 46606313)
26. Igaki H, Kato H, Ando N, et al.: A randomized trial of postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for clinical stage II/III squamous cell carcinoma of the thoracic esophagus (JCOG 9907). American Society of Clinical Oncology 44th Annual Meeting 2008. Abstract #4510. J Clin Oncol 2008;26:(May 20 suppl; abstr 4510).
27. Ando N, Kato H, Shioda M, et al.: A randomized trial of postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for localized squamous cell carcinoma of the thoracic esophagus (JCOG 9907). Proc GI Can Symp 2008;1:abstract 10.
28. Ando N, Iizuka T, Ide H, et al.: Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 2003;21:4592-4596. (Pubitemid 46594032)
29. Muro K: Chemoradiotherapy. Nippon Geka Gakkai Zasshi 2008;109:15-20. [in Japanese].
30. Iizuka T, Isono K, Kakegawa T, et al.: Parameters linked to ten-year survival in Japan of resected esophageal carcinoma. Japanese Committee for Registration of Esophageal Carcinoma Cases. Chest 1989;96:1005-1011.
31. Ando N, Ozawa S, Kitagawa Y, et al.: Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 2000;232:225-232. (Pubitemid 30616724)
32. Nishimura Y, Suzuki M, Nakamatsu K, et al.: Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Int J Radiat Oncol Biol Phys 2002;53:134-139. (Pubitemid 34465816)
33. Bedenne L, Michel P, Bouché O, et al.: Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007;25:1160-1168. (Pubitemid 46640561)
34. Stahl M, Stuschke M, Lehmann N, et al.: Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005;23:2310-2317. (Pubitemid 46218723)